US Patent Issued to AUTOLUS on May 12 for "Chimeric receptor comprising a ligand binding domain and an endodomain comprising a cytokine receptor endodomain and an intracellular T cell signalling domain" (British Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,088, issued on May 12, was assigned to AUTOLUS Ltd. (London).

"Chimeric receptor comprising a ligand binding domain and an endodomain comprising a cytokine receptor endodomain and an intracellular T cell signalling domain" was invented by Martin Pule (London), Shaun Cordoba (London) and Matteo Righi (London).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a chimeric receptor which comprises: a ligand-binding exodomain; and an endodomain which comprises: (i) a cytokine receptor endodomain; and (ii) an intracellular T cell signalling domain."

The patent was filed on Dec. 22, 2021, under Application No. 17/560,022.

*For fu...